References
- Chow , S. C. , Liu , J. P. ( 2000 ). Design and Analysis of Bioavailability and Bioequivalence Studies . Marcel Dekker, Inc.
- FDA ( 1992 ). FDA guidance on statistical procedures for bioequivalence using a standard two-treatment crossover design .
- FDA ( 2001 ). FDA guidance on statistical approaches to establishing bioequivalence .
- FDA ( 2003 ). FDA revised guidance on bioavailability and bioequivalence studies for orally administered drug products: general considerations .
- Jones , B. , Kenward , M. G. ( 2003 ). Design and Analysis of Cross-Over Trials . New York : Chapman and Hall .
- Lee , Y. , Nelder , J. A. ( 1996 ). Hierarchical generalized linear models (with discussion) . J. Roy. Statist. Soc. Ser. B 58 : 619 – 678 .
- Lee , Y. , Nelder , J. A. ( 2001 ). Hierarchical generalised linear models: asynthesis of generalised linear models, random-effect models and structured dispersions . Biometrika 88 : 987 – 1006 .
- Liu , J. P. , Weng , C. S. ( 1993 ). Evaluation of parametric and nonparametric two one-sided tests procedures for assessing bioequivalence of average bioavailability . J. Biopharmaceut. Statist. 3 : 85 – 102 .
- McGilchrist , C. A. ( 1994 ). Estimation in generalized mixed models . J. Roy. Statist. Soc. Ser. B 56 : 61 – 69 .
- Patterson , S. D. ( 2001 ). A review of the development of biostatistical design and analysis techniques for assessing in vivo bioequivalence. Part 1 . Ind. J. Pharmaceut. Sci. 63 : 81 – 100 .
- Schuirmann , D. J. ( 1987 ). A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability . J. Pharmacokinet. Biopharmaceut. 15 : 657 – 680 .
- Xie , C. ( 2003 ). Hierarchical Quasi-Likelihood and Their Applications . Ph.D dissertation, Department of Mathematics and Statistics, University of Guelph .